Ascorbic acid enhancement of desferrioxamine-induced urinary iron excretion in thalassemia major.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001205:Ascorbic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003676:Deferoxamine / Q000627:therapeutic use*; D004357:Drug Synergism; D006801:Humans; D007501:Iron / Q000097:blood / Q000378:metabolism / Q000652:urine*; D013789:Thalassemia / Q000628:therapy / Q000652:urine*; D065227:Transfusion Reaction
D007501:Iron; D003676:Deferoxamine; D001205:Ascorbic Acid